Blandt de 176 patienter, der fik Vectibix efter progression på BSC alene, var responsraten (investigators vurdering) 11, 4% (95% CI:
Among the 176 patients who received Vectibix after progression on BSC alone, the response rate (investigator assessment) was 11.4% (95% CI: